Dr. Varun Sundaram, a urologist at Urology Austin, joined Studio 512 Co-Host Rosie Newberry to talk about SpaceOAR Hydrogel and Rezūm Water Vapor Therapy. “The two treatments we commonly use are ...

Results published in the International Journal of Radiation Oncology Biology and Physics show on average no long-term declines in bowel and urinary quality of life for patients and 78% reduction in ...

WALTHAM, Mass.--(BUSINESS WIRE)--Augmenix, Inc., a privately held company developing minimally invasive hydrogel products to improve outcomes following cancer radiotherapy, today announced FDA ...

NEW YORK CITY, N.Y. (Ivanhoe Newswire) – This year, more than 162,000 men will be diagnosed with prostate cancer. Cancer treatment, while life-saving, can cause incontinence and erectile dysfunction.

Dr. Varun Sundaram, a urologist at Urology Austin, joined Studio 512 Co-Host Rosie Newberry to talk about SpaceOAR Hydrogel and Rezūm Water Vapor Therapy. Prostate cancer is the most common form of ...

According to the American Cancer Society (ACS), prostate cancer is the second most common cancer in American men and the second-leading cause of cancer-related death in the U.S. More than 164,000 new ...

DALLAS, March 14, 2018 /PRNewswire-PRWeb/ -- Urology Clinics of North Texas is pleased to announce the arrival of a new system for men choosing to undergo radiation therapy for prostate cancer. The ...

A Navy veteran and football coach tackles prostate cancer diagnosis, with family’s support. Steve seemed to have it all. After a career in the U.S. Navy, he and his wife of 38 years were living in St.

Prostate cancer is one of the most common cancers for men with more than 183,000 new diagnoses each year. It's a highly treatable cancer, with options ranging from watchful waiting to surgery to ...

This year, more than 162,000 men will be diagnosed with prostate cancer. Cancer treatment, while life-saving, can cause incontinence and erectile dysfunction, but a new outpatient procedure can ...

WALTHAM, Mass.—April 2, 2015—Augmenix, Inc., a privately held company developing minimally invasive hydrogel products to improve outcomes following cancer radiotherapy, today announced FDA clearance ...